PT  - JOURNAL ARTICLE
AU  - Alguwaihes, Abdullah M.
AU  - Alhozali, Amani
AU  - Yahia, Moataz M.
AU  - Abdel-Nabi, Tarek
AU  - Hassan Hatahet, Mohamed
AU  - Albalkhi, Nader I.
AU  - Al Sifri, Saud
TI  - The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE study
AID  - 10.15537/smj.2023.44.1.20220402
DP  - 2023 Jan 01
TA  - Saudi Medical Journal
PG  - 57--66
VI  - 44
IP  - 1
4099  - http://smj.org.sa/content/44/1/57.short
4100  - http://smj.org.sa/content/44/1/57.full
SO  - Saudi Med J2023 Jan 01; 44
AB  - Objectives: To investigate cardiovascular disease (CVD) prevalence in adult patients with type 2 diabetes mellitus (T2DM) in Saudi Arabia using data from the CAPTURE cross-sectional study.Methods: CAPTURE was a non-interventional, multinational study carried out between December 2018 and September 2019. In Saudi Arabia, clinical (including medication) and demographic data were collected across 7 sites (Alhada Armed Forces Hospital, Taif; King Saud University Medical City, King Saud University, Riyadh; Specialized Medical Centre Hospital, Riyadh; King Abdulaziz University Hospital, Jeddah; King Abdulaziz Hospital for National Guard, Al Ahsa; Diabetes and Endocrinology Center, Buraidah; and Dallah Hospital, Riyadh, Saudi Arabia) from adults aged ≥18 years. The prevalence of CVD was estimated and weighted according to care setting, with data between groups not statistically compared.Results: Among the 883 adults enrolled in this study (566 from primary care, 317 from secondary care), 158 had established CVD, making the weighted prevalence of 18% (95% CI: [15.5-20.5]). The weighted prevalence of atherosclerotic CVD was 15.1% (95% CI: [12.8-17.5]), accounting for 82.4% of the CVD cases. Coronary heart disease was the most common subtype of CVD (13.4%), followed by cerebrovascular disease (1.7%). A total of 23.6% of patients were treated with glucose-lowering agents with proven cardiovascular benefit.Conclusion: In Saudi Arabia, approximately one in 5 adults with T2DM had established CVD, lower than the global prevalence, possibly because of disparities in patient characteristics, potential genetic predispositions, or a lack of accurate documentation due to poor coordination between care settings.